Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
Researchers are investigating a new medication that may be able to reduce or prevent hearing loss in patients with NTM who are treated with amikacin, a common IV antibiotic.
A new investigational nebulizer treatment is being tested for common types of NTM lung infection. Researchers need volunteers with NTM infections to participate in the ICoN-1 study.
Researchers are investigating a new medication that may be able to reduce or prevent hearing loss in patients with NTM who are treated with amikacin, a common IV antibiotic.
A new investigational nebulizer treatment is being tested for common types of NTM lung infection. Researchers need volunteers with NTM infections to participate in the ICoN-1 study.
Researchers are investigating a new medication that may be able to reduce or prevent hearing loss in patients with NTM who are treated with amikacin, a common IV antibiotic.
A new investigational nebulizer treatment is being tested for common types of NTM lung infection. Researchers need volunteers with NTM infections to participate in the ICoN-1 study.